In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
COVID-19: Information for Patients and Caregivers

We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.

What you need to know

1792 News Items found
MSK multiple myeloma specialist Urvy Shah
Diets for MGUS, Smoldering Myeloma, and Multiple Myeloma: Q&A With MSK Cancer and Nutrition Experts

Learn how eating a plant-based diet may prevent MGUS and smoldering myeloma from developing into multiple myeloma, according to MSK research.
MSK patient Michael Simien poses with his bicycle in front of a fountain in New York City
This Remarkable MSK Patient Is Living With Two Kinds of Stage 4 Cancer

Learn how it's possible to stay active even with two types of advanced cancer — lung cancer and mantle cell lymphoma — thanks to innovative treatments at MSK.
At Work
Ivan Maillard
A ‘Matchmaker’ Between the Lab and the Clinic: At Work With Ivan Maillard

A passion for both science and the humanities has informed the life and career of Dr. Ivan Maillard, who was recently selected to lead the Division of Hematologic Malignancies at MSK.
Tammela Lab
Cancer Risk Declines in Old Age, New MSK Research Helps Explain Why

A new laboratory study provides evidence about how advanced age can be protective against cancer — with implications for treating patients in different age groups.
Jhalene Mundin
How MSK Cares for a Young Woman Living With Stage 4 EGFR Lung Cancer

Learn how a young woman diagnosed with stage 4 non-small cell lung cancer had many treatment options because she came to MSK first.
In the Clinic
MSK thoracic surgeon Alexis Chidi
Six Things You Need to Know About Lung Cancer Screening and CT Scans

Find out why people at risk of lung cancer are not getting screened and why they should.
Rob with his wife and daughter
FDA Approves Zanidatamab for Biliary Tract Cancers With High HER2 Levels 

Learn more about a new treatment for biliary tract cancers with high levels of HER2. The drug zanidatamab has been approved by the FDA, thanks to a clinical trial co-led by MSK.
A researcher working in an MSK lab
MSK Research Highlights, November 21, 2024

New MSK research investigates how pancreatic cancer cells regulate their genome to avoid immune attack; shows promise against glioblastoma in mouse models; and develops a new method to study cancer evolution.
Sohrab Shah
Cancer-Like Mutations in Healthy Cells Point to Origins of Breast Cancer

A multi-institution team co-led by MSK researchers has pinpointed what could be the early genetic origins of breast cancer.
Michael Rosensweig with dog
FDA Approves Revumenib, a Menin Inhibitor, for Aggressive Leukemia

Based on a clinical trial led by an MSK investigator, the FDA has approved revumenib (Revuforj®) for patients one year and older who have leukemia that has come back after treatment and whose cancer carries a molecular change called a KMT2A translocation.